The benefits to expanded vaccination programs in low- and middle-income countries (LMICs) simply dwarf the cost. Rich countries should be donating more vaccines faster to poorer countries. It is difficult to think of a more urgent global priority and it is surely a best buy in international development.
CGD Policy Blogs
Drugs created with billions in government support, bought almost exclusively by governments and international agencies are shrouded in secrecy: who is paying how much for delivery of what by when is a matter of guesswork and estimate.
Charles Kenny launches his latest book The Plague Cycle: The Unending War Between Humanity and Infectious Disease.
Without global action, by 2050 there could be as many as 10 million antimicrobial resistance-related deaths each year. An important—and often overlooked—part of the problem is the overuse of antibiotics in farm animals. CGD recently convened a roundtable discussion with technical experts to discuss possible ways to strengthen global cooperation to address livestock’s contribution to AMR. Drawing on that productive discussion, we outline steps that could help make inroads into the problem.
Kellyanne Conway called him a “man of action” after a whirlwind first week in which President Trump signed 14 Executive Orders and presidential memoranda, covering most of his key campaign issue areas from health to immigration to trade. In a series of blogs, CGD experts have been examining how some of these specific policy intentions could impact development progress. As you would expect from a group of economists, we believe in—and encourage—evidence-based policymaking, and here we look at what the existing evidence and research tell us about how likely these Executive Orders are to achieve the president’s stated goals.
Empowering Women Can Make America Great – Podcast with Amanda Glassman, Mayra Buvinic, and Charles Kenny
The scale of the turnout at the Women’s Marches across the world recently, along with President Trump’s early reinstatement of a ban on US funding for organizations that offer family planning services in foreign countries, seem to suggest an administration already at odds with an entire gender. On this week’s podcast, three CGD senior fellows weigh in on the evidence that engaging and empowering women—both at home and overseas—makes good sense, especially in an America-First strategy.
An Ambitious Goal for International Cooperation in 2017: A Global Treaty to Tackle Antimicrobial Resistance
Earlier this month, evidence emerged that a Nevada woman who died last September had contracted a superbug resistant to all 26 available antibiotics, including colistin, the drug of last resort. If left unchecked, antimicrobial resistance (AMR) could cause up to 10 million deaths a year by 2050 with a cumulative loss of $100 trillion to the global economy. The misuse of antibiotics in human medicine allows bacteria to evolve resistance to many life-saving drugs. But their excessive and inappropriate use in farm animals—which consume 70-80 percent of antibiotics sold in the United States—is another key factor accelerating drug resistance globally.
Most antibiotics around the world today are fed to farm animals to promote growth and prevent diseases fostered by crowded conditions on factory farms. There is an urgent need to find alternatives to keep animals healthy, and preserve crucial antibiotics for human health. One way to do that would be to create an international treaty not to use antibiotics in livestock feed — and probiotics, like those found in yogurt, may be a stepping stone toward that goal.
While the numbers coming out of side events at Addis were hardly worth the single shake of a string-free pom-pom, and the launch of a Global Partnership for Sustainable Development Data raised a lot of questions, there were some bright spots in the US commitments to that partnership.
In Health Spending, Middle-Income Countries Face a Priorities Ditch, Not a Financing Ditch – But That Still Merits Aid
After a successful replenishment earlier this year, the board of Gavi, the Vaccine Alliance, is thinking through how to maximize the impact of the money it has raised. One hot issue is graduation from Gavi support. Currently, the Alliance uses an income cutoff loosely based on eligibility for IDA — soft loans from the World Bank.